Search Results 1031-1040 of 17598 for Assay
Patients with disease measurable by serum light chain assay alone are eligible (defined as ≥ 100 mg/L on involved light chain). Patients must not have any ...
Correlative assays will focus upon the incidence of infectious complications in this patient population, the evolution of HIV infection and immunological ...
Negative TB test (PPD, interferon-gamma release assay, ELISPOT testing) within 1 year prior to enrollment. Subjects with a history of TB (positive TB test ...
Qualifying deleterious SPOP mutation detected on any archival genomic assay (tissue and/or liquid biopsy) is acceptable for study inclusion. Qualifying ...
Known history of serum or plasma progranulin level less than one standard deviation below the normal patient mean for the laboratory performing the assay.
D., director of assay development, designed a novel test to find compounds that bind to cyclophilin B. The research team found several hits in molecules ...
... assay. Locally advanced or metastatic breast cancer with either measurable (according to RECIST 1.1 [Eisenhauer, et al, 2009]) or non-measurable lesions ...
While assays exist to detect and identify the presence of microbes, the tests can be negative, making it challenging to determine if a patient has an infection.
... assay (CBA) within 6 months prior to randomization * Participant must be clinically stable at the time of the Screening Visit and during the Screening ...
Patient must have BRAF V600E or BRAF V600K tumor genotype based on a Clinical Laboratory Improvement Act (CLIA) approved assay. Patient must have measurable ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.